EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $674,010 | -39.2% | 42,740 | -25.0% | 0.00% | – |
| Q2 2023 | $1,108,197 | -46.8% | 57,006 | -22.3% | 0.00% | – |
| Q1 2023 | $2,082,358 | +275.9% | 73,400 | +287.3% | 0.00% | – |
| Q4 2022 | $553,938 | +11.0% | 18,951 | +0.2% | 0.00% | – |
| Q3 2022 | $499,000 | +6.6% | 18,904 | +100.0% | 0.00% | – |
| Q1 2022 | $468,000 | -79.4% | 9,451 | -78.8% | 0.00% | – |
| Q4 2021 | $2,268,000 | +21.9% | 44,532 | +33.5% | 0.00% | – |
| Q3 2021 | $1,861,000 | +365.2% | 33,369 | +256.7% | 0.00% | – |
| Q2 2021 | $400,000 | +60.6% | 9,355 | +57.0% | 0.00% | – |
| Q1 2021 | $249,000 | -75.0% | 5,957 | -74.6% | 0.00% | – |
| Q3 2020 | $997,000 | +4.9% | 23,472 | +18.5% | 0.00% | – |
| Q2 2020 | $950,000 | -52.5% | 19,800 | -54.4% | 0.00% | – |
| Q1 2020 | $1,998,000 | -67.1% | 43,445 | -57.1% | 0.00% | -100.0% |
| Q4 2019 | $6,080,000 | +307.0% | 101,200 | +283.1% | 0.00% | – |
| Q3 2019 | $1,494,000 | -94.4% | 26,417 | -94.5% | 0.00% | -100.0% |
| Q2 2019 | $26,909,000 | +370.4% | 483,296 | +326.7% | 0.00% | +50.0% |
| Q1 2019 | $5,720,000 | +12.0% | 113,273 | -10.6% | 0.00% | 0.0% |
| Q4 2018 | $5,106,000 | -70.1% | 126,747 | -48.5% | 0.00% | -66.7% |
| Q3 2018 | $17,049,000 | +5.1% | 245,900 | +14.6% | 0.01% | 0.0% |
| Q2 2018 | $16,229,000 | +114.9% | 214,500 | +49.6% | 0.01% | +200.0% |
| Q1 2018 | $7,553,000 | +12.6% | 143,335 | +14.1% | 0.00% | 0.0% |
| Q4 2017 | $6,708,000 | +25.5% | 125,578 | +40.2% | 0.00% | 0.0% |
| Q3 2017 | $5,344,000 | -44.7% | 89,600 | -26.9% | 0.00% | -50.0% |
| Q2 2017 | $9,672,000 | -2.2% | 122,600 | +2.9% | 0.00% | -20.0% |
| Q1 2017 | $9,886,000 | -59.2% | 119,200 | -61.0% | 0.01% | -61.5% |
| Q4 2016 | $24,254,000 | +41.2% | 305,700 | +24.6% | 0.01% | +44.4% |
| Q3 2016 | $17,171,000 | +216.4% | 245,300 | +75.3% | 0.01% | +200.0% |
| Q2 2016 | $5,427,000 | -36.3% | 139,900 | -33.5% | 0.00% | -40.0% |
| Q1 2016 | $8,521,000 | -7.2% | 210,400 | +103.2% | 0.01% | +25.0% |
| Q4 2015 | $9,182,000 | -24.3% | 103,553 | -36.8% | 0.00% | -33.3% |
| Q3 2015 | $12,133,000 | +102.8% | 163,898 | +121.5% | 0.01% | +200.0% |
| Q2 2015 | $5,982,000 | +380.1% | 73,978 | +148.7% | 0.00% | +100.0% |
| Q1 2015 | $1,246,000 | – | 29,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |